BioHarvest Sciences Inc. (BHST) KPIs and segments
Close on Nov 17, 2026Market cap $27.65MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive BioHarvest Sciences's business
BioHarvest Sciences's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
Entity-wide($M) | 34.5 | 25.2 | 12.7 | |
Products($M) | 32.6 | 24.9 | 12.7 | |
North America($M) | 30.6 | 23.0 | 10.9 | |
Israel($M) | 3.92 | 2.18 | 1.81 | |
CDMO Services($M) | 1.88 | 0.28 | 0 | |
Products($M) | 19.2 | 13.8 | 5.63 | |
CDMO Services($M) | 1.30 | 0.10 | 0 | |
United States($M) | 0.08 | -0.24 | 0.14 | |
Canada($M) | -4.51 | -7.54 | -4.86 | |
Israel($M) | -6.63 | -5.13 | -7.85 | |
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-03-31.
See a number that looks wrong?